Efg Asset Management (North America) Corp. Vera Therapeutics, Inc. Transaction History
Efg Asset Management (North America) Corp.
- $566 Million
- Q2 2024
A detailed history of Efg Asset Management (North America) Corp. transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Efg Asset Management (North America) Corp. holds 31,444 shares of VERA stock, worth $1.39 Million. This represents 0.2% of its overall portfolio holdings.
Number of Shares
31,444
Previous 10,343
204.01%
Holding current value
$1.39 Million
Previous $445,000
155.51%
% of portfolio
0.2%
Previous 0.08%
Shares
2 transactions
Others Institutions Holding VERA
# of Institutions
182Shares Held
54.7MCall Options Held
42.2KPut Options Held
121K-
Avoro Capital Advisors LLC New York, NY4.31MShares$190 Million2.13% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.62MShares$160 Million0.02% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$147 Million0.0% of portfolio
-
Abingworth LLP London, X02.96MShares$131 Million19.0% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA2.79MShares$123 Million5.61% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $1.19B
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...